CPHI News and Press, China Pharma Holdings Inc. From 02/26/20

These 5 Penny Stocks Could Be Worth Your Attention Right Now It isn’t difficult to see that the broader markets are having a tough time right now. With COVID-19 infecting the news cycle, daily, it isn’t a bull market like most have become used to. However, we (PennyStocks.com) mi...

Penny Stocks To Watch After Coronavirus Comments This topic continues to captivate headlines: the coronavirus. A number of penny stocks have greatly benefited from speculation on “what’s next” for the virus spread. Today may have opened a bigger can of worms for investor...

Some financial outlets may tell you that all penny stocks should be avoided like the plague. But it really comes down to your personal strategy. No matter the investment, if you are well-educated, fully aware of the risks, and see an opportunity to capitalize, what’s there to avoid? One...

With another choppy market session in the books, investors remain focused on small-cap stocks. Also known as penny stocks , these low-priced equities tend to perform well during times of both market uncertainty and stagnation. This time around we might be seeing both. During the last 6 sessions...

Will These Be On Your Monday Morning Penny Stocks Watch List? This weekend, something big is happening. No, it’s not a new TV show, and actually it’s not even the Big Game on Sunday . This weekend thousands of investors are researching the market to get ready for Monday. That al...

China Pharma (NYSEMKT: CPHI ): Q3 GAAP EPS of -$0.02. Revenue of $2.38M (+3.5% Y/Y) Press Release More news on: China Pharma Holdings, Inc., Earnings news and commentary, Healthcare stocks news, ,

HAIKOU CITY, China , Nov. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China , today announced financial resu...

HAIKOU CITY, China , Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China , today announced that ...

China Pharma Holdings Inc. (CPHI) Q2 2019 Earnings Conference Call August 15, 2019 08:30 AM ET Company Participants Diana Huang – Manager-Investor Relations Zhilin Li – President and Chief Executive Officer and Interim Chief Financial Officer Sam Hsing – Corp...

China Pharma (NYSEMKT: CPHI ): Q2 GAAP EPS of -$0.02. More news on: China Pharma Holdings, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...